TheEdgeResearch
Home / Stocks / ZTS

Zoetis Inc. (ZTS)

NYSE Healthcare Drug Manufacturers - General
$75.90 ▼ -3.57%
Market Cap
$31.82B
Sector
Healthcare
Industry
Drug Manufacturers - General
Beta
0.74
52-Wk Range
72.38-161.77
CEO
Kristin C. Peck
Country
US
Currency
USD

Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immu…

Open full interactive analysis & DCF →